The Bio Report – Podcast: Boosting the Power of Dendritic Cancer Vaccines

Diakonos Oncology Presents Promising Preliminary Data from Phase 1 Study of DOC1021 Cell-Based Immunotherapy in Pancreatic Cancer at Society for Immunotherapy of Cancer 40th Annual Meeting

Pancreatic Cancer Clinical Trial Data for Diakonos Oncology’s DOC1021 Cell-Based Immunotherapy to be Presented at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Patient-Derived Dendritic Cell Immunotherapy Targets Difficult-to-Treat Cancers